250 related articles for article (PubMed ID: 38337390)
1. Possible Effect of Polycystic Ovary Syndrome (PCOS) on Cardiovascular Disease (CVD): An Update.
Profili NI; Castelli R; Gidaro A; Manetti R; Maioli M; Petrillo M; Capobianco G; Delitala AP
J Clin Med; 2024 Jan; 13(3):. PubMed ID: 38337390
[TBL] [Abstract][Full Text] [Related]
2. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.
Wild RA; Carmina E; Diamanti-Kandarakis E; Dokras A; Escobar-Morreale HF; Futterweit W; Lobo R; Norman RJ; Talbott E; Dumesic DA
J Clin Endocrinol Metab; 2010 May; 95(5):2038-49. PubMed ID: 20375205
[TBL] [Abstract][Full Text] [Related]
3. Polycystic ovary syndrome: a "risk-enhancing" factor for cardiovascular disease.
Guan C; Zahid S; Minhas AS; Ouyang P; Vaught A; Baker VL; Michos ED
Fertil Steril; 2022 May; 117(5):924-935. PubMed ID: 35512976
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome.
Glintborg D; Rubin KH; Nybo M; Abrahamsen B; Andersen M
Cardiovasc Diabetol; 2018 Mar; 17(1):37. PubMed ID: 29519249
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular disease risk in offspring of polycystic ovary syndrome.
Shawky NM
Front Endocrinol (Lausanne); 2022; 13():977819. PubMed ID: 36531474
[TBL] [Abstract][Full Text] [Related]
6. Subclinical cardiovascular disease and polycystic ovary syndrome.
Gomez JMD; VanHise K; Stachenfeld N; Chan JL; Merz NB; Shufelt C
Fertil Steril; 2022 May; 117(5):912-923. PubMed ID: 35512975
[TBL] [Abstract][Full Text] [Related]
7. Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype.
Armeni E; Stamatelopoulos K; Rizos D; Georgiopoulos G; Kazani M; Kazani A; Kolyviras A; Stellos K; Panoulis K; Alexandrou A; Creatsa M; Papamichael C; Lambrinoudaki I
J Hypertens; 2013 Oct; 31(10):1998-2004. PubMed ID: 24107731
[TBL] [Abstract][Full Text] [Related]
8. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
[TBL] [Abstract][Full Text] [Related]
9. Polycystic ovary syndrome and chronic inflammation: pharmacotherapeutic implications.
Sirmans SM; Weidman-Evans E; Everton V; Thompson D
Ann Pharmacother; 2012 Mar; 46(3):403-18. PubMed ID: 22388330
[TBL] [Abstract][Full Text] [Related]
10. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
[TBL] [Abstract][Full Text] [Related]
11. Relation of NT-probnp levels and cardiovascular disease risk factors in lean women with polycystic ovary syndrome.
Karadağ C; Yoldemir T
J Obstet Gynaecol; 2019 Nov; 39(8):1154-1159. PubMed ID: 31215274
[TBL] [Abstract][Full Text] [Related]
12. Is There Really Increased Cardiovascular Morbidity in Women with Polycystic Ovary Syndrome?
Carmina E; Lobo RA
J Womens Health (Larchmt); 2018 Nov; 27(11):1385-1388. PubMed ID: 30199308
[TBL] [Abstract][Full Text] [Related]
13. Association of polycystic ovary syndrome with cardiovascular disease among female hospitalizations in the United States.
Dwivedi AK; Vishwakarma D; Dubey P; Reddy S
Eur J Endocrinol; 2023 Jun; 188(6):555-563. PubMed ID: 37307574
[TBL] [Abstract][Full Text] [Related]
14. Polycystic ovary syndrome and metabolic syndrome.
Ali AT
Ceska Gynekol; 2015 Aug; 80(4):279-89. PubMed ID: 26265416
[TBL] [Abstract][Full Text] [Related]
15. The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome.
Meun C; Gunning MN; Louwers YV; Peters H; Roos-Hesselink J; Roeters van Lennep J; Rueda Ochoa OL; Appelman Y; Lambalk N; Boersma E; Kavousi M; Fauser BC; Laven JS;
Clin Endocrinol (Oxf); 2020 Feb; 92(2):150-158. PubMed ID: 31638273
[TBL] [Abstract][Full Text] [Related]
16. Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention.
Osibogun O; Ogunmoroti O; Michos ED
Trends Cardiovasc Med; 2020 Oct; 30(7):399-404. PubMed ID: 31519403
[TBL] [Abstract][Full Text] [Related]
17. Arterial stiffness measured by cardio-ankle vascular index in Korean women with polycystic ovary syndrome.
Kim J; Choi SY; Park B; Park HE; Lee H; Kim MJ; Kim SM; Hwang KR; Choi YM
J Obstet Gynaecol; 2019 Jul; 39(5):681-686. PubMed ID: 30983450
[TBL] [Abstract][Full Text] [Related]
18. Staying up late increases cardiovascular disease risk in women with polycystic ovary syndrome.
Zeng X; Ye J; Yan X; Zhang J; Guo J; Tao X; Zheng X; Tong M; Huang Y; Zhang M; He C; Chen X; Liu C
Hum Reprod; 2023 Jul; 38(7):1359-1367. PubMed ID: 37279883
[TBL] [Abstract][Full Text] [Related]
19. Clinical update on screening, diagnosis and management of metabolic disorders and cardiovascular risk factors associated with polycystic ovary syndrome.
Huang G; Coviello A
Curr Opin Endocrinol Diabetes Obes; 2012 Dec; 19(6):512-9. PubMed ID: 23108199
[TBL] [Abstract][Full Text] [Related]
20. Intercellular adhesion molecule-1 expression and serum levels as markers of pre-clinical atherosclerosis in polycystic ovary syndrome.
Rashad NM; El-Shal AS; Abomandour HG; Aboelfath AMK; Rafeek MES; Badr MS; Ali AE; Yousef MS; Fathy MA; Sharaf El Din MTA
J Ovarian Res; 2019 Oct; 12(1):97. PubMed ID: 31629408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
